GlobeNewswire Clinical StudiesOriginal article
New MotherToBaby Study Targets Pregnancy Data Gap for Newer Eczema Treatment
Trial StartEbglyssNeutral
AI Analysis
Summary
MotherToBaby launched a U.S. and Canadian pregnancy study to gather human safety data on Ebglyss, a newer moderate-to-severe eczema treatment with insufficient existing pregnancy-related data.
Clinical Trial Data
Importance:3/10
Sentiment:
0.00
pregnancyeczemaclinical trialsafety dataregulatory
Read the original article
Published by GlobeNewswire Clinical Studies on August 13, 2026 1:55 PM
